Is a complete CABA research report available?

No complete published report is available for Cabaletta Bio, Inc. (CABA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cabaletta Bio, Inc. (CABA)

NASDAQ: CABA · USD

$1.52

+0.07 (+4.5%)· Recorded snapshot

Market cap	257.7M
Net income (ttm)	-181.3M
EPS (ttm)	-$1.54
Shares out	169.5M
Volume	5,392,073
Beta	3.47

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -181.3M
EPS (ttm): -$1.54
Market cap: 257.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001759138
Company name	Cabaletta Bio, Inc.
Country	United States
Country code	US
CUSIP number	12674W109
Earnings date	2026-11-09
Earnings time	bmo
Employees	158
Employees change	-9
Employees growth	-5.39%
Enterprise value	$58.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2019-10-25
Is primary listing	Yes
Is SPAC	No
ISIN number	US12674W1099
Last 10-K release date	2026-03-23
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$257.7M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$1.52
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	CABA
U.S. state	Pennsylvania
Website	https://www.cabalettabio.com

Metric

Value

Amount currency

USD

CIK code

0001759138

Company name

Cabaletta Bio, Inc.

Country

United States

Country code

CUSIP number

12674W109

Earnings date

2026-11-09

Earnings time

bmo

Employees

158

Employees change

-9

Employees growth

-5.39%

Enterprise value

$58.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2019-10-25

Is primary listing

Yes

Is SPAC

ISIN number

US12674W1099

Last 10-K release date

2026-03-23

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$257.7M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$1.52

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

CABA

U.S. state

Pennsylvania

Website

https://www.cabalettabio.com

Metric	Value
Earnings yield	-101.45%
FCF / EV yield	-299.21%
FCF yield	-61.46%
P/B ratio	1.16x
Price / tangible book value	1.19x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-101.45%

FCF / EV yield

-299.21%

FCF yield

-61.46%

P/B ratio

1.16x

Price / tangible book value

1.19x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-1.1M
ROA	-48.19%
ROA (5Y)	-34.83%
ROCE	-85.56%
ROE	-93.2%
ROE (5Y)	-62.93%
ROIC	-52.74%

Metric

Value

Profit per employee

$-1.1M

ROA

-48.19%

ROA (5Y)

-34.83%

ROCE

-85.56%

ROE

-93.2%

ROE (5Y)

-62.93%

ROIC

-52.74%

Metric	Value
EPS growth quarters	4
EPS growth years	1
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-283,000
Depreciation and amortization	$1.4M
EBIT	$-185.5M
EBITDA	$-184.1M
EPS	$-1.54
FCF per share	$-0.91
Financing cash flow	$182.8M
Free cash flow	$-154.2M
Free cash flow minus SBC	$-175M
Investing cash flow	$50.7M
Net borrowing	$-9.8M
Net cash flow	$79.5M
Net income	$-181.3M
Operating cash flow minus SBC	$-174.8M
Operating income	$-185.5M
Stock-based compensation	$20.8M

Metric

Value

Capital expenditures

$-283,000

Depreciation and amortization

$1.4M

EBIT

$-185.5M

EBITDA

$-184.1M

EPS

$-1.54

FCF per share

$-0.91

Financing cash flow

$182.8M

Free cash flow

$-154.2M

Free cash flow minus SBC

$-175M

Investing cash flow

$50.7M

Net borrowing

$-9.8M

Net cash flow

$79.5M

Net income

$-181.3M

Operating cash flow minus SBC

$-174.8M

Operating income

$-185.5M

Stock-based compensation

$20.8M

Metric	Value
Book value per share	$1.26
Debt / equity	0.12
Interest coverage	-80.94
Long-term assets	$25.7M
Long-term liabilities	$6.2M
Net cash (debt)	$199.4M
Net cash / market cap	79.46%
Net cash growth	17.43%
Net debt / equity	-0.95
Piotroski F-Score	2
Property, plant and equipment	$19.5M
Shareholders' equity	$210.6M
Tangible book value	$210.6M
Tangible book value per share	$1.26
Total assets	$256.7M
Total cash	$225.1M
Total debt	$25.7M
Total liabilities	$46.1M
WACC	21.84%

Metric

Value

Book value per share

$1.26

Debt / equity

0.12

Interest coverage

-80.94

Long-term assets

$25.7M

Long-term liabilities

$6.2M

Net cash (debt)

$199.4M

Net cash / market cap

79.46%

Net cash growth

17.43%

Net debt / equity

-0.95

Piotroski F-Score

Property, plant and equipment

$19.5M

Shareholders' equity

$210.6M

Tangible book value

$210.6M

Tangible book value per share

$1.26

Total assets

$256.7M

Total cash

$225.1M

Total debt

$25.7M

Total liabilities

$46.1M

WACC

21.84%

Metric	Value
Current assets	$231M
Current liabilities	$39.9M
Current ratio	5.79
Net working capital	$-14.5M
Quick ratio	5.64
Working capital	$191.1M

Metric

Value

Current assets

$231M

Current liabilities

$39.9M

Current ratio

5.79

Net working capital

$-14.5M

Quick ratio

5.64

Working capital

$191.1M

Metric	Value
Buyback yield / dilution	-121.83%
Dividend yield	0%
Shareholder yield	-121.83%

Metric

Value

Buyback yield / dilution

-121.83%

Dividend yield

Shareholder yield

-121.83%

Metric	Value
150-day SMA	$2.86
1D price change	4.47%
1M price change	-30.43%
1M total return	-30.43%
1W price change	-10.56%
1W total return	-10.56%
1Y price change	-48.39%
1Y return CAGR	-48.41%
1Y total return	-48.39%
20-day SMA	$1.69
200-day SMA	$2.86
3M price change	-47.06%
3M total return	-47.06%
3Y price change	-88.75%
3Y return CAGR	-51.72%
3Y total return	-88.75%
50-day SMA	$2.37
50-day SMA vs 200-day SMA	50under200
52-week high	$4.23
52-week high date	2026-05-06
52-week low	$1.32
52-week low date	2026-10-27
5Y price change	-88.9%
5Y return CAGR	-35.57%
5Y total return	-88.9%
6M price change	-50.52%
6M total return	-50.52%
All-time high	$26.35
All-time high date	2024-02-08
All-time low	$0.59
All-time low date	2022-09-23
Average true range (ATR)	$0.15
Average volume	5M
Beta (1Y)	2.94
Beta (2Y)	3.99
Beta (5Y)	3.47
Change from 52-week high	-64.07%
Change from 52-week low	15.15%
Change from all-time high	-94.54%
Change from all-time low	144.07%
Change from open	5.19%
Day's gap	-0.69%
Dollar volume	$8.2M
High price	$1.53
Low price	$1.43
Monthly RSI	39.2
Open price	$1.45
Position in 52-week range	95%
Premarket change	1.72%
Premarket close	$1.46
Premarket price	$1.48
Premarket volume	4.9K
Previous close	$1.46
Price vs 150-day SMA	-49.62%
Price vs 20-day SMA	-14.69%
Price vs 200-day SMA	-49.69%
Price vs 50-day SMA	-39.11%
Relative volume	1.07
Return from IPO open	-83.56%
Return from IPO price	-86.55%
RSI	31.92
Sharpe ratio	-0.3
Sharpe ratio (3Y)	-0.24
Sharpe ratio (5Y)	0.18
Sortino ratio	-0.44
Sortino ratio (3Y)	-0.3
Sortino ratio (5Y)	0.33
Volume	5.4M
Weekly RSI	33.06
YTD price change	-34.25%
YTD total return	-34.25%

Metric

Value

150-day SMA

$2.86

1D price change

4.47%

1M price change

-30.43%

1M total return

-30.43%

1W price change

-10.56%

1W total return

-10.56%

1Y price change

-48.39%

1Y return CAGR

-48.41%

1Y total return

-48.39%

20-day SMA

$1.69

200-day SMA

$2.86

3M price change

-47.06%

3M total return

-47.06%

3Y price change

-88.75%

3Y return CAGR

-51.72%

3Y total return

-88.75%

50-day SMA

$2.37

50-day SMA vs 200-day SMA

50under200

52-week high

$4.23

52-week high date

2026-05-06

52-week low

$1.32

52-week low date

2026-10-27

5Y price change

-88.9%

5Y return CAGR

-35.57%

5Y total return

-88.9%

6M price change

-50.52%

6M total return

-50.52%

All-time high

$26.35

All-time high date

2024-02-08

All-time low

$0.59

All-time low date

2022-09-23

Average true range (ATR)

$0.15

Average volume

Beta (1Y)

2.94

Beta (2Y)

3.99

Beta (5Y)

3.47

Change from 52-week high

-64.07%

Change from 52-week low

15.15%

Change from all-time high

-94.54%

Change from all-time low

144.07%

Change from open

5.19%

Day's gap

-0.69%

Dollar volume

$8.2M

High price

$1.53

Low price

$1.43

Monthly RSI

39.2

Open price

$1.45

Position in 52-week range

95%

Premarket change

1.72%

Premarket close

$1.46

Premarket price

$1.48

Premarket volume

4.9K

Previous close

$1.46

Price vs 150-day SMA

-49.62%

Price vs 20-day SMA

-14.69%

Price vs 200-day SMA

-49.69%

Price vs 50-day SMA

-39.11%

Relative volume

1.07

Return from IPO open

-83.56%

Return from IPO price

-86.55%

RSI

31.92

Sharpe ratio

-0.3

Sharpe ratio (3Y)

-0.24

Sharpe ratio (5Y)

0.18

Sortino ratio

-0.44

Sortino ratio (3Y)

-0.3

Sortino ratio (5Y)

0.33

Volume

5.4M

Weekly RSI

33.06

YTD price change

-34.25%

YTD total return

-34.25%

Metric	Value
Float	141.5M
Float percentage	83.45%
Shares change (QoQ)	34.93%
Shares change (YoY)	121.83%
Shares held by insiders	0.97%
Shares held by institutions	78.77%
Shares outstanding	169.5M
Short % of float	27.29%
Short % of shares	22.77%
Short ratio	6.3 days

Metric

Value

Float

141.5M

Float percentage

83.45%

Shares change (QoQ)

34.93%

Shares change (YoY)

121.83%

Shares held by insiders

0.97%

Shares held by institutions

78.77%

Shares outstanding

169.5M

Short % of float

27.29%

Short % of shares

22.77%

Short ratio

6.3 days

Cabaletta Bio, Inc. (CABA)

Price

Financial snapshot

Fair-value bridge

Latest news · CABA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CABA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CABA

Frequently asked questions